K279-1249 Screening compound: 2-({3-[2-(BENZYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-CYCLOHEXYLACETAMIDE

K279-1249 Screening compound: 2-({3-[2-(BENZYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-CYCLOHEXYLACETAMIDE
K279-1249 Screening compound: 2-({3-[2-(BENZYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-CYCLOHEXYLACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-1249
2-({3-[2-(BENZYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-CYCLOHEXYLACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-1249

Molecular Formula

C27H29N5O3S (C27 H29 N5 O3 S)

Compound Name

2-({3-[2-(BENZYLAMINO)-2-OXOETHYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)-N~1~-CYCLOHEXYLACETAMIDE

IUPAC name

n/a

SMILES

O=C(CC1N2C(SCC(NC3CCCCC3)=O)=Nc(cccc3)c3C2=NC1=O)NCc1ccccc1

InChI

InChI=1S/C27H29N5O3S/c33-23(28-16-18-9-3-1-4-10-18)15-22-26(35)31-25-20-13-7-8-14-21(20)30-27(32(22)25)36-17-24(34)29-19-11-5-2-6-12-19/h1,3-4,7-10,13-14,19,22H,2,5-6,11-12,15-17H2,(H,28,33)(H,29,34)/t22-/m0/s1

InChI Key

IAESXFPAUYXJCY-QFIPXVFZSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

503.63

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.627

Distribution Coefficient, logD

2.626

Water Solubility, LogSw

-3.43

Polar Surface Area

83.820

Acid Dissociation Constant (pKa)

11.05

Base Dissociation Constant (pKb)

4.86

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

37.00

K279-1249 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with K279-1249 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-1249?
Check Price and Availability of K279-1249, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-1249 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-1249
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-1249
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-1249 available by request